VectorB2B will be at “Infectious Diseases Virtual Partnering”

We are very pleased to be attending the Infectious Diseases Virtual Partnering from 2-4 December, 2020. If you have any questions, please contact our specialist.

Vector B2B – Drug Development will present our new services available to all pharmaceutical & biotechnology companies developing new treatments for many infectious diseases for which there are not satisfactory preventive tools or treatment options

More News

VectorB2B participa ativamente no Encontro Ciência 2024

Estamos a organizar a sessão científica intitulada “Como podem os CoLABs apoiar os desafios da Saúde Global?” https://lnkd.in/dnDVwafm Juntem-se a nós no próximo dia 4 de Julho, 11h30-13h30 Visitem-nos no nosso stand!

VectorB2B is now member of Europharm SMC

The European Pharmaceutical Association representing Small and Medium Sized Pharmaceutical Companies. Europharm’s mission is to support and defend the interests of SMEs, in order to enhance their competitiveness and entrepreneurship within the global framework of the pharmaceutical industry. Europharm SMC is a unique business network of pharmaceutical SMEs coming from all European countries who share this common goal. The […]

VectorB2B is member of Health Cluster Portugal!

O Health Cluster Portugal conta com um novo Associado / The Health Cluster Portugal has a new Member: VectorB2B – Drug Development https://lnkd.in/dBafiV6N hashtag#healthclusterportugal hashtag#healthportugal

© 2024 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form